Cargando…

Abiraterone Acetate Withdrawal Syndrome: Does It Exist?

In 2011 abiraterone acetate (AA) was approved for the treatment of castrate-resistant metastatic prostate cancer patients who have failed docetaxel chemotherapy. We report the case of a patient who experienced a confirmed PSA decrease of ≤50% after stopping AA, mimicking an antiandrogen withdrawal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauthier, Hélène, Bousquet, Guilhem, Pouessel, Damien, Culine, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409514/
https://www.ncbi.nlm.nih.gov/pubmed/23525261
http://dx.doi.org/10.1159/000341564

Ejemplares similares